Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease

Abstract Background Patients and caregivers express a desire for accurate prognostic information about time to institutionalization and mortality. Previous studies predicting institutionalization and mortality focused on the dementia stage. However, Alzheimer’s disease (AD) is characterized by a lon...

Full description

Bibliographic Details
Main Authors: Arenda Mank, Ingrid S. van Maurik, Judith J. M. Rijnhart, Els D. bakker, Vincent Bouteloup, Lisa Le Scouarnec, Charlotte E. Teunissen, Frederik Barkhof, Philip Scheltens, Johannes Berkhof, Wiesje M. van der Flier
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13195-022-01053-0
_version_ 1828149669675401216
author Arenda Mank
Ingrid S. van Maurik
Judith J. M. Rijnhart
Els D. bakker
Vincent Bouteloup
Lisa Le Scouarnec
Charlotte E. Teunissen
Frederik Barkhof
Philip Scheltens
Johannes Berkhof
Wiesje M. van der Flier
author_facet Arenda Mank
Ingrid S. van Maurik
Judith J. M. Rijnhart
Els D. bakker
Vincent Bouteloup
Lisa Le Scouarnec
Charlotte E. Teunissen
Frederik Barkhof
Philip Scheltens
Johannes Berkhof
Wiesje M. van der Flier
author_sort Arenda Mank
collection DOAJ
description Abstract Background Patients and caregivers express a desire for accurate prognostic information about time to institutionalization and mortality. Previous studies predicting institutionalization and mortality focused on the dementia stage. However, Alzheimer’s disease (AD) is characterized by a long pre-dementia stage. Therefore, we developed prediction models to predict institutionalization and mortality along the AD continuum of cognitively normal to dementia. Methods This study included SCD/MCI patients (subjective cognitive decline (SCD) or mild cognitive impairment (MCI)) and patients with AD dementia from the Amsterdam Dementia Cohort. We developed internally and externally validated prediction models with biomarkers and without biomarkers, stratified by dementia status. Determinants were selected using backward selection (p<0.10). All models included age and sex. Discriminative performance of the models was assessed with Harrell’s C statistics. Results We included n=1418 SCD/MCI patients (n=123 died, n=74 were institutionalized) and n=1179 patients with AD dementia (n=413 died, n=453 were institutionalized). For both SCD/MCI and dementia stages, the models for institutionalization and mortality included after backward selection clinical characteristics, imaging, and cerebrospinal fluid (CSF) biomarkers. In SCD/MCI, the Harrell’s C-statistics of the models were 0.81 (model without biomarkers: 0.76) for institutionalization and 0.79 (model without biomarker: 0.76) for mortality. In AD-dementia, the Harrell’s C-statistics of the models were 0.68 (model without biomarkers: 0.67) for institutionalization and 0.65 (model without biomarker: 0.65) for mortality. Models based on data from amyloid-positive patients only had similar discrimination. Conclusions We constructed prediction models to predict institutionalization and mortality with good accuracy for SCD/MCI patients and moderate accuracy for patients with AD dementia. The developed prediction models can be used to provide patients and their caregivers with prognostic information on time to institutionalization and mortality along the cognitive continuum of AD.
first_indexed 2024-04-11T21:33:40Z
format Article
id doaj.art-1a1160c2108245568ccdb44efb065220
institution Directory Open Access Journal
issn 1758-9193
language English
last_indexed 2024-04-11T21:33:40Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Alzheimer’s Research & Therapy
spelling doaj.art-1a1160c2108245568ccdb44efb0652202022-12-22T04:01:50ZengBMCAlzheimer’s Research & Therapy1758-91932022-08-0114111210.1186/s13195-022-01053-0Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s diseaseArenda Mank0Ingrid S. van Maurik1Judith J. M. Rijnhart2Els D. bakker3Vincent Bouteloup4Lisa Le Scouarnec5Charlotte E. Teunissen6Frederik Barkhof7Philip Scheltens8Johannes Berkhof9Wiesje M. van der Flier10Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmcAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmcAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health InstituteAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmcUniversité Bordeaux, Inserm U1219, Institut de Santé Publique, d’Epidémiologie et de Développement (ISPED)Université Bordeaux, Inserm U1219, Institut de Santé Publique, d’Epidémiologie et de Développement (ISPED)Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam, The Netherlands Neuroscience, VU University Medical Center Amsterdam, Amsterdam UMCDepartment of Diagnostic Radiology, VU University Medical Center Amsterdam, Amsterdam UMCAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmcAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health InstituteAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmcAbstract Background Patients and caregivers express a desire for accurate prognostic information about time to institutionalization and mortality. Previous studies predicting institutionalization and mortality focused on the dementia stage. However, Alzheimer’s disease (AD) is characterized by a long pre-dementia stage. Therefore, we developed prediction models to predict institutionalization and mortality along the AD continuum of cognitively normal to dementia. Methods This study included SCD/MCI patients (subjective cognitive decline (SCD) or mild cognitive impairment (MCI)) and patients with AD dementia from the Amsterdam Dementia Cohort. We developed internally and externally validated prediction models with biomarkers and without biomarkers, stratified by dementia status. Determinants were selected using backward selection (p<0.10). All models included age and sex. Discriminative performance of the models was assessed with Harrell’s C statistics. Results We included n=1418 SCD/MCI patients (n=123 died, n=74 were institutionalized) and n=1179 patients with AD dementia (n=413 died, n=453 were institutionalized). For both SCD/MCI and dementia stages, the models for institutionalization and mortality included after backward selection clinical characteristics, imaging, and cerebrospinal fluid (CSF) biomarkers. In SCD/MCI, the Harrell’s C-statistics of the models were 0.81 (model without biomarkers: 0.76) for institutionalization and 0.79 (model without biomarker: 0.76) for mortality. In AD-dementia, the Harrell’s C-statistics of the models were 0.68 (model without biomarkers: 0.67) for institutionalization and 0.65 (model without biomarker: 0.65) for mortality. Models based on data from amyloid-positive patients only had similar discrimination. Conclusions We constructed prediction models to predict institutionalization and mortality with good accuracy for SCD/MCI patients and moderate accuracy for patients with AD dementia. The developed prediction models can be used to provide patients and their caregivers with prognostic information on time to institutionalization and mortality along the cognitive continuum of AD.https://doi.org/10.1186/s13195-022-01053-0Alzheimer’s diseaseMild cognitive impairmentSubjective cognitive declinePrognosisMortalityInstitutionalization
spellingShingle Arenda Mank
Ingrid S. van Maurik
Judith J. M. Rijnhart
Els D. bakker
Vincent Bouteloup
Lisa Le Scouarnec
Charlotte E. Teunissen
Frederik Barkhof
Philip Scheltens
Johannes Berkhof
Wiesje M. van der Flier
Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease
Alzheimer’s Research & Therapy
Alzheimer’s disease
Mild cognitive impairment
Subjective cognitive decline
Prognosis
Mortality
Institutionalization
title Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease
title_full Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease
title_fullStr Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease
title_full_unstemmed Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease
title_short Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease
title_sort development of multivariable prediction models for institutionalization and mortality in the full spectrum of alzheimer s disease
topic Alzheimer’s disease
Mild cognitive impairment
Subjective cognitive decline
Prognosis
Mortality
Institutionalization
url https://doi.org/10.1186/s13195-022-01053-0
work_keys_str_mv AT arendamank developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT ingridsvanmaurik developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT judithjmrijnhart developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT elsdbakker developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT vincentbouteloup developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT lisalescouarnec developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT charlotteeteunissen developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT frederikbarkhof developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT philipscheltens developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT johannesberkhof developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease
AT wiesjemvanderflier developmentofmultivariablepredictionmodelsforinstitutionalizationandmortalityinthefullspectrumofalzheimersdisease